A Cost-Effectiveness Analysis of Commonly Used Biologic Drugs for the Treatment of Moderate-To-Severe Psoriasis in the United States
May 1, 2018, 00:00 AM
10.1016/j.jval.2018.04.1630
https://www.valueinhealthjournal.com/article/S1098-3015(18)31936-3/fulltext
Section Title :
Section Order :
856
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(18)31936-3&doi=10.1016/j.jval.2018.04.1630